An FDA advisory panel has unanimously voted to recommend COVID-19 jabs to kids under the age of five, the last age group still deemed “unprotected” against the Communist Chinese virus by the FDA.
Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc's (MRNA.O) COVID-19 vaccine for children and teens aged 6 to 17 years of age.
The U.S. Food and Drug Administration’s vaccine advisory council will meet June 14 to consider granting Emergency Use Authorization (EUA) of the Pfizer and Moderna COVID-19 vaccines for children under 5 years old, even though the White House last week announced it is already filling orders for the vaccines placed by states and healthcare providers.
VAERS data released Friday by the Centers for Disease Control and Prevention show 1,295,329 reports of adverse events from all age groups following COVID-19 vaccines, including 28,714 deaths and 236,767 serious injuries between Dec. 14, 2020, and June 3, 2022.
A U.S. military official predicted a pause in the administration of the Moderna and Pfizer COVID-19 vaccines could happen if more cases of post-vaccination heart inflammation were detected, according to newly obtained emails.
Members of Congress today demanded answers from Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration (FDA), as the agency reviews Emergency Use Authorization (EUA) for COVID-19 shots in children age 5 and under.
Defending the Republic, a Texas-based non-profit filed a Freedom of Information Act lawsuit against the Food and Drug Administration for refusing to turn over records related to the approval of Moderna’s COVID-19 vaccines.
